Beryl Drugs Limited (BOM:524606)
20.80
0.00 (0.00%)
At close: Jul 29, 2025
Beryl Drugs Market Cap
Beryl Drugs has a market cap or net worth of 107.57 million as of July 30, 2025. Its market cap has decreased by -34.76% in one year.
Market Cap
107.57M
Enterprise Value
140.16M
Revenue
211.46M
Ranking
n/a
PE Ratio
18.61
Stock Price
20.80
Market Cap Chart
Since June 14, 2005, Beryl Drugs's market cap has increased from 3.69M to 107.57M, an increase of 2,811.79%. That is a compound annual growth rate of 18.23%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 29, 2025 | 105.49M | -42.46% |
Dec 31, 2024 | 183.34M | 63.50% |
Dec 29, 2023 | 112.14M | 70.08% |
Dec 30, 2022 | 65.93M | 7.26% |
Dec 31, 2021 | 61.47M | 54.00% |
Dec 31, 2020 | 39.91M | 60.94% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Reliance Industries | 17.68T |
HDFC Bank | 15.37T |
Bharti Airtel | 11.61T |
Tata Consultancy Services | 11.35T |
ICICI Bank | 10.54T |
State Bank of India | 7,445.59B |
Infosys | 6,282.84B |
Hindustan Unilever | 5,675.20B |